Capital Research Global Investors
GH icon

Capital Research Global Investors’s Guardant Health GH Stock Holding History

Capital Research Global Investors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,301,472
Closed -$62.3M – 420
2023
Q4 		$62.3M Hold
2,301,472
– – 0.02% 308
2023
Q3 		$68.2M Buy
2,301,472
+611,191
+36% +$21.5M 0.02% 303
2023
Q2 		$60.5M Buy
1,690,281
+690,281
+69% +$19.8M 0.02% 318
2023
Q1 		$23.4M Sell
1,000,000
-1,001,782
-50% -$28.6M 0.01% 366
2022
Q4 		$54.4M Sell
2,001,782
-148,722
-7% -$6.81M 0.02% 320
2022
Q3 		$116M Buy
2,150,504
+1,171
+0.1% +$60.1K 0.04% 253
2022
Q2 		$86.7M Sell
2,149,333
-1,860,172
-46% -$92.2M 0.03% 290
2022
Q1 		$266M Sell
4,009,505
-3,918,197
-49% -$268M 0.07% 212
2021
Q4 		$793M Buy
7,927,702
+2,640,910
+50% +$273M 0.18% 122
2021
Q3 		$661M Buy
5,286,792
+3,128,063
+145% +$372M 0.15% 138
2021
Q2 		$268M Buy
2,158,729
+120,975
+6% +$16.3M 0.06% 220
2021
Q1 		$311M Buy
2,037,754
+4,991
+0.2% +$754K 0.08% 209
2020
Q4 		$262M Buy
2,032,763
+40,093
+2% +$4.61M 0.07% 217
2020
Q3 		$223M Buy
1,992,670
+39,650
+2% +$3.63M 0.07% 206
2020
Q2 		$158M Buy
1,953,020
+800,887
+70% +$64.5M 0.05% 229
2020
Q1 		$80.2M Buy
1,152,133
+28,921
+3% +$2.22M 0.03% 256
2019
Q4 		$87.8M Buy
1,123,212
+44,061
+4% +$3.18M 0.03% 274
2019
Q3 		$68.9M Buy
1,079,151
+458,852
+74% +$40.4M 0.02% 296
2019
Q2 		$53.5M Buy
+620,299
New +$47.4M 0.02% 309

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Capital Research Global Investors's GH Position: Q1 2024 in Review

Capital Research Global Investors sold out of Guardant Health (GH) in Q1 2024, closing a stake of 2,301,472 shares — an estimated $62.3M sold.

Capital Research Global Investors first reported a position in GH in Q2 2019 and held it in 19 quarters. The position peaked at $793M in Q4 2021. 258 funds tracked by Wall St. Rank hold GH as of Q1 2024.

  • Capital Research Global Investors reported no remaining Guardant Health position as of Q1 2024 after selling out during the quarter.
  • Capital Research Global Investors sold 2,301,472 Guardant Health shares in Q1 2024, an estimated $62.3M.
  • Capital Research Global Investors first reported a position in Guardant Health in Q2 2019 and held it in 19 quarters.
  • Capital Research Global Investors's Guardant Health position peaked at $793M in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Guardant Health as of Q1 2024.

Based on Capital Research Global Investors's 13F filing for Q1 2024, filed 14 May 2024.